Correlation of body mass index with toxicity and survival in locoregionally advanced head and neck cancer patients treated with induction chemotherapy and concurrent chemoradiotherapy

被引：0
|
作者：
Jain, A. K. [1 ]
Salama, J. K. [1 ]
Stenson, K. M. [1 ]
Blair, E. [1 ]
Cohen, E. E. [1 ]
Witt, M. [1 ]
Haraf, D. J. [1 ]
Vokes, E. E. [1 ]
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6074
引用
收藏
页数：2
相关论文
共 50 条
  • [21] THE CORRELATION OF SPECIFIC VARIABLES OF TUMOR DIFFERENTIATION WITH RESPONSE RATE AND SURVIVAL IN PATIENTS WITH ADVANCED HEAD AND NECK-CANCER TREATED WITH INDUCTION CHEMOTHERAPY
    ENSLEY, JF
    KISH, JA
    WEAVER, AA
    JACOBS, JR
    HASSAN, M
    CUMMINGS, G
    ALSARRAF, M
    CANCER, 1989, 63 (08) : 1487 - 1492
  • [22] Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer
    Vokes, EE
    Kies, MS
    Haraf, DJ
    Stenson, K
    List, M
    Humerickhouse, R
    Dolan, ME
    Pelzer, H
    Sulzen, L
    Witt, ME
    Hsieh, YC
    Mittal, BB
    Weichselbaum, RR
    JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (08) : 1652 - 1661
  • [23] Induction plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy in elderly patients with locoregionally advanced nasopharyngeal carcinoma
    Chen, Lin
    Li, Kunpeng
    Li, Qingjie
    Ji, Pengjie
    Huang, Chenglong
    Tang, Linglong
    RADIOTHERAPY AND ONCOLOGY, 2024, 200
  • [24] Concurrent chemoradiotherapy versus induction chemotherapy followed by chemoradiotherapy (sequential approach) in the management of head and neck cancer
    Fabregas, Jesus C.
    Loaiza-Bonilla, Arturo
    Talebi, Toni N.
    Warsch, Sean
    Fernandez, Gustavo
    Raez, Luis E.
    Santos, Edgardo S.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (09) : 1065 - 1072
  • [25] Induction Chemotherapy Before Chemoradiotherapy in Locally Advanced Head and Neck Cancer: The Future?
    Paccagnella, Adriano
    Mastromauro, Cataldo
    D'Amanzo, Paola
    Ghi, Maria Grazia
    ONCOLOGIST, 2010, 15 : 8 - 12
  • [26] Concomitant chemoradiotherapy alone or with induction chemotherapy in advanced head and neck cancer.
    Teixeira, R.
    Cavaleiro, A.
    Vieira, P.
    Aveiro, F.
    Vieira, G.
    RADIOTHERAPY AND ONCOLOGY, 2017, 122 : 36 - 36
  • [27] The End of TPF Induction for locally advanced Head and Neck Cancer? Induction Chemotherapy followed by Cetuximab and Radiotherapy is not superior to concurrent Chemoradiotherapy
    Hermann, R. M.
    Christiansen, H.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2019, 195 (03) : 281 - 284
  • [28] Impact of pretreatment body mass index on the survival of head and neck cancer patients
    Yang, Zheng
    Mansour, Jobran
    Sun, Peng
    Wei, Peng
    Dahlstrom, Kristina R.
    Zafereo, Mark
    Li, Guojun
    Gross, Neil D.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2024, 46 (08): : 1881 - 1892
  • [29] Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: Improved disease control and survival
    Kies, MS
    Haraf, DJ
    Athanasiadis, I
    Kozloff, M
    Mittal, B
    Pelzer, H
    Rademaker, AW
    Wenig, B
    Weichselbaum, RR
    Vokes, EE
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2715 - 2721
  • [30] Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
    Haddad, Robert
    O'Neill, Anne
    Rabinowits, Guilherme
    Tishler, Roy
    Khuri, Fadlo
    Adkins, Douglas
    Clark, Joseph
    Sarlis, Nicholas
    Lorch, Jochen
    Beitler, Jonathan J.
    Limaye, Sewanti
    Riley, Sarah
    Posner, Marshall
    LANCET ONCOLOGY, 2013, 14 (03) : 257 - 264
12345